Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) has earned a consensus rating of “Buy” from the six research firms that are currently covering the firm, Marketbeat Ratings reports. Four analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12 month price target among analysts that have covered the stock in the last year is $10.00.
A number of analysts have issued reports on BIOX shares. Oppenheimer cut their price objective on shares of Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating for the company in a report on Tuesday, January 28th. Lake Street Capital dropped their price target on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating for the company in a research report on Friday, February 7th. Finally, Canaccord Genuity Group reduced their price target on Bioceres Crop Solutions from $9.50 to $7.00 and set a “buy” rating on the stock in a research report on Friday, February 7th.
View Our Latest Analysis on Bioceres Crop Solutions
Hedge Funds Weigh In On Bioceres Crop Solutions
Bioceres Crop Solutions Stock Performance
NASDAQ:BIOX opened at $4.78 on Friday. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.37. The stock has a 50 day simple moving average of $6.57 and a 200 day simple moving average of $7.70. Bioceres Crop Solutions has a 1-year low of $4.70 and a 1-year high of $13.80. The stock has a market cap of $299.75 million, a P/E ratio of 239.12 and a beta of 0.57.
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last announced its earnings results on Monday, November 11th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.11). Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. The business had revenue of $92.60 million during the quarter, compared to the consensus estimate of $117.15 million. During the same period in the previous year, the firm posted ($0.07) EPS. Research analysts anticipate that Bioceres Crop Solutions will post 0.12 earnings per share for the current year.
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Featured Stories
- Five stocks we like better than Bioceres Crop Solutions
- 3 Monster Growth Stocks to Buy Now
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Are Penny Stocks a Good Fit for Your Portfolio?
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Best Stocks Under $5.00
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.